EMJ Oncology 9 [Supplement 1] . 2021

FOUR leading experts in the field of oncology were brought together in an interview to discuss the epidemiology, treatment decisions, and emerging treatment paradigms of EGFR-mutated advanced non-small cell lung cancer (NSCLC). Recent clinical evidence was also reviewed, including the RELAY trial.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?